Figma vs. UiPath: Which Technology Stock Is a Better Buy in 2026?

Figma's FY2025 revenue rose 41% to nearly $1.1 billion, but it reported a roughly $1.25 billion net loss and its shares fell about 16% after its latest report as AI investment weighed on margins and operating losses widened. UiPath's FY2026 revenue grew 12.7% to nearly $1.6 billion, with net income of about $282 million and four consecutive GAAP-profitable quarters; it also raised its full-year outlook. The article favors UiPath for its lower valuation (17.0x forward P/E versus Figma's 77.9x) and improving profitability, while noting risks for both companies.

Analysis

The relative setup favors PATH over FIG, but the key distinction is earnings quality—not simply growth versus valuation. PATH’s profitability can support rerating only if it persists through renewals and converts into cash after stock-based compensation; the reported cash-generation figure still overstates owner economics. Conversely, FIG’s faster growth does not yet show that AI investment is producing paid adoption or defending retention. Its post-report selloff may already price in some margin deterioration, so initiating a short solely on the headline reaction risks selling into a rebound.

Over the next 1–3 months, watch PATH guidance, subscription/renewal trends, and dilution-adjusted cash flow; also test whether AI-agent deployments expand automation budgets or displace conventional RPA. For FIG, monitor operating expense growth against revenue, enterprise retention, and evidence that AI features support pricing rather than merely raise infrastructure and development costs. A longer-term risk to PATH is platform vendors absorbing workflow automation into broader AI suites; FIG faces substitution risk if design capabilities become bundled into incumbents’ products. A potential second-order beneficiary of enterprise AI deployment is SNOW if automation drives incremental data workloads, but the partnership reference alone does not establish material revenue contribution.

Contrarian point: PATH’s low stated multiple may reflect durable skepticism about growth and product relevance, not a mispricing; FIG’s premium may persist if collaboration remains sticky and AI monetization emerges. The valuation comparison is not fully decision-ready: verify the measurement date, share-price basis, and earnings definition—especially FIG’s forward P/E despite reported losses—before trading on those multiples.

Key Decisions for Investors

• Prefer PATH to FIG on a relative basis, but stage any long PATH / short FIG pair rather than chase the post-earnings move; keep exposure beta-conscious and confirm valuation inputs first.
• Treat PATH as a 1–3 month execution trade: add only if subsequent guidance and renewals support durable GAAP profitability and cash generation after SBC. Reassess if profitability reverses or dilution-adjusted cash conversion weakens.
• Do not short FIG solely on the selloff. Stay underweight or wait for stabilization; turn more constructive only if AI-related revenue or retention gains begin to outpace operating-cost growth.
• Track whether agentic automation expands PATH’s addressable workflows or displaces its RPA use cases. Evidence of broad platform substitution would falsify the relative-long thesis; material FIG margin recovery without weaker growth would also narrow the pair.